• Users Online: 787
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2022  |  Volume : 16  |  Issue : 5  |  Page : 57-62

Endemic parasitic disease - Expert group opinion for South Asia for solid-organ transplantation − Leishmaniasis, malaria, toxoplasmosis, filariasis, and strongyloidiasis


1 Institute of Infectious Diseases, Apollo Hospital, Chennai, Tamil Nadu, India
2 Department of Infectious Diseases, Rajiv Gandhi Cancer Hospital, New Delhi, India
3 Department of Nephrology, Madras Medical College, Chennai, Tamil Nadu, India
4 Department of Infectious Diseases, Apollo Hospital, Chennai, Tamil Nadu, India
5 Department of Nephrology, Popular Medical College, Dhaka, Bangladesh

Correspondence Address:
Dr. Venkatasubramanian Ramasubramanian
Apollo Hospitals, Adjunct Prof Infectious Diseases - Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijot.ijot_117_21

Rights and Permissions

Although parasitic infections including malaria, leishmania, and toxoplasmosis contribute to a significant burden of the morbidity and mortality of global populations, they remain woefully understudied in solid-organ transplantation with recommendations mainly based on expert opinions. This paradox is due to the fact that the geographic prevalence of most of these infections is restricted to the developing world where priorities of care are different due to economic constraints. Limited availability of transplant programs where parasitic infections are endemic, challenges in diagnosis, re-activation or recrudescence of latent infections which may present at a later date, the lesser impact of these infections in the immune-suppressed host and limited availability of drugs used in the treatment of some of these infections may influence therapeutic interventions. In the Indian sub-continent, malaria, visceral leishmaniasis (VL), filariasis, strongyloidiasis, and toxoplasmosis are endemic. India contributes to 4% of the total global burden of cases of malaria and has the highest number of cases among the South Asian countries. VL is restricted to Bihar and West Bengal in India and liposomal amphotericin, the drug of choice is still prohibitively expensive. The impact of toxoplasmosis, filariasis, and strongyloidiasis in solid-organ transplant is still limited compared to other infections. Challenges are mainly related to donor screening and exclusion as applying western recommendations to these endemic infections may not be practical. Early diagnosis and appropriate therapy improve outcomes.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed336    
    Printed6    
    Emailed0    
    PDF Downloaded52    
    Comments [Add]    

Recommend this journal